Effect of H. Pylori Eradication on Alleviating Symptoms in Functional Dyspepsia Patients

• Status: Recruiting
• Trial end date: 2023-12-31
• Target enrollment: 0
• Participant gender: All

Summary

In patients with Helicobacter pylori-positive functional dyspepsia, long-term follow-up for 6 months after standard triple therapy first-line eradication treatment, the rate of symptom disappearance and degree of improvement of functional dyspepsia were confirmed through changes in symptom scores and changes in drug usage, and eradication treatment The purpose of this study is to confirm the rate of symptom disappearance according to the results.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wonkwang University Hospital

Criteria

Inclusion Criteria:

• Male and female outpatients between the ages of 19 and 75

• Who have symptoms of functional dyspepsia (early fullness, postprandial discomfort, epigastric pain, epigastric soreness) that correspond to Rome criteria 4 (diagnostic criteria questionnaire)

Exclusion Criteria:

• Small intestine and large intestine disease within 6 months of the screening visit (Visit 1)

• liver, pancreatobiliary disease within 6 months of the screening visit (Visit 1)

• peptic ulcer within 6 months of the screening visit (Visit 1)